BioPharma Credit (UK) Alpha and Beta Analysis
| BPCR Stock | 0.89 0.01 1.11% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioPharma Credit PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioPharma Credit over a specified time horizon. Remember, high BioPharma Credit's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioPharma Credit's market risk premium analysis include:
Beta (0.13) | Alpha 0.014 | Risk 0.95 | Sharpe Ratio 0.023 | Expected Return 0.0218 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioPharma |
BioPharma Credit Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioPharma Credit market risk premium is the additional return an investor will receive from holding BioPharma Credit long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioPharma Credit. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioPharma Credit's performance over market.| α | 0.01 | β | -0.13 |
BioPharma Credit expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioPharma Credit's Buy-and-hold return. Our buy-and-hold chart shows how BioPharma Credit performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BioPharma Credit Market Price Analysis
Market price analysis indicators help investors to evaluate how BioPharma Credit stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioPharma Credit shares will generate the highest return on investment. By understating and applying BioPharma Credit stock market price indicators, traders can identify BioPharma Credit position entry and exit signals to maximize returns.
BioPharma Credit Return and Market Media
The median price of BioPharma Credit for the period between Tue, Aug 26, 2025 and Mon, Nov 24, 2025 is 0.9 with a coefficient of variation of 1.55. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.9, and mean deviation of 0.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | BioPharma Credit PLC Declares Interim Dividend in Respect of the Quarterly Financial Period Ending 30 September 2025, Payable on 31 October 2025 - MarketScreene... | 09/18/2025 |
2 | Why BioPharma Credit PLC stock trades below fair value - Quarterly Portfolio Summary Growth-Oriented Investment Plans - newser.com | 10/06/2025 |
3 | Can BioPharma Credit PLC stock stage a strong rebound this quarter - Gap Up Expert Curated Trade Setups - newser.com | 10/29/2025 |
4 | What technical patterns form on BioPharma Credit PLC stock charts - New Guidance Reliable Price Breakout Alerts - newser.com | 11/05/2025 |
5 | Will BioPharma Credit PLC stock announce special dividend - New Guidance Free Safe Entry Trade Signal Reports - newser.com | 11/11/2025 |
6 | Will BioPharma Credit PLC stock benefit from sector leadership - Insider Selling AI Forecasted Stock Moves - newser.com | 11/18/2025 |
7 | REG - BioPharma Credit PLC - Net Asset Value and Monthly Factsheet - TradingView | 11/21/2025 |
About BioPharma Credit Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioPharma or other stocks. Alpha measures the amount that position in BioPharma Credit PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioPharma Credit in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioPharma Credit's short interest history, or implied volatility extrapolated from BioPharma Credit options trading.
Build Portfolio with BioPharma Credit
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for BioPharma Stock Analysis
When running BioPharma Credit's price analysis, check to measure BioPharma Credit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPharma Credit is operating at the current time. Most of BioPharma Credit's value examination focuses on studying past and present price action to predict the probability of BioPharma Credit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPharma Credit's price. Additionally, you may evaluate how the addition of BioPharma Credit to your portfolios can decrease your overall portfolio volatility.